Wells Messersmith, MD, specializes in gastrointestinal (GI) cancers, or cancers of the gut. As the division head of the University of Colorado School of Medicine’s Division of Medical Oncology, Messersmith is pushing the frontiers of anticancer treatments from the intersection of precision medicine and immunotherapy.
Messersmith and his research partners are developing clinical trials of novel immune therapies, specifically for GI cancers, with a focus on colorectal cancer – the third most common cancer in the United States. He is currently leading a combination immunotherapy trial for colorectal cancer at the CU Anschutz Medical Campus, where is also a professor of medical oncology, and serves as associate director for clinical services at the CU Cancer Center.
Below, this prolific yet unassuming oncology powerhouse shares insight about what motivates him, at work and beyond.
Original source can be found here.
